Request Processed
Your registration request has been processed. We will contact you soon.
Register
First name
Last name
Email
Company
Toggle navigation
Toggle navigation
Login
Register
About
Contact Us
1
2
3
4
5
…
Next ›
Last »
Prevision Policy Clips | FDA Chief Counsel Will Be Hilary Perkins After HHS Reorganizes
March 12, 2025
Makary’s Team Takes Shape: FDA Deputy For Legislation Is Former Hill Staffer With User Fee/21CC Experience Graham; Chief Of Staff Is Traficant
March 11, 2025
Flat-Line Funding Is Best Case For FDA Heading Into Shutdown Uncertainty, Return-To-Office Deadlines; Pediatric PRV Still In Limbo
March 11, 2025
Prevision Policy Clips | FDA Medical Reviewers, Manufacturing Inspectors Not Eligible for HHS “Buyout”
March 11, 2025
Prevision Policy Clips | CMS Nominee Oz Set For Confirmation Hearing March 14
March 10, 2025
ICER Panel Endorses Value Of Vertex’ Journavx Compared To Opioids, But Questions Benefits Compared To NSAIDs; Coverage Policies Will Be Key To Uptake
March 7, 2025
Prevision Policy Clips | FDA Commissioner Nominee Makary Breezes Through Senate Hearing
March 7, 2025
VRBPAC Will Be Back, But Maybe Not For Flu, FDA Commissioner Nominee Makary Says; Is Another Advisory Committee Reset Coming?
March 7, 2025
Generics, Biosimilars – And OTCs – Are Part Of FDA Role In Drug Pricing Policy, Commissioner Nominee Makary Says
March 6, 2025
FDA Nominee Makary Promises “Surgical” Approach To FDA Cuts – But No Guarantee He Will Be Wielding The Scalpel; “MAHA” Themes Coming To FDA, But Toned Down From RFK
March 6, 2025
Prevision Policy Clips | Trump’s 10-To-1 Deregulation Policy Will Force FDA To Give “Care And Consideration”
March 6, 2025
Drug Pricing, Researcher Conflicts Of Interest With Big Pharma Get Attention During NIH Nominee Bhattacharya’s Senate HELP Confirmation Hearing
March 5, 2025
Prevision Policy Clips | Trump Praises MAHA Commission, Announces “Reciprocal Tariffs” On April 2
March 5, 2025
Prevision Policy Clips | Drug Prices, Pharma Tariffs And Medicaid Cuts Are Topics To Watch For During President Trump's Address
March 4, 2025
Prevision Policy Clips | FDA Return To Office Procedures Are Underway; Initial Process Is Relatively Smooth
March 3, 2025
Controlled Correspondence: FDA Encourages Generic Sponsors To Ask Better Questions; SBIA Event Includes Plea For Industry To Affirm Value Of FDA Public Meetings
February 28, 2025
FDA Deadline Tracker: No Sign Of Slippage On Drug Reviews In First Month Under Trump
February 28, 2025
Prevision Policy Clips | FDA Commissioner Nominee Makary Set For March 6 Confirmation Hearing
February 28, 2025
Advisory Committee Tracker: FDA Resumes Public Speaking Engagements – But Advisory Committees Still MIA
February 27, 2025
PRV Renewal, PBM Reform Are Bipartisan Issues At House Health Subcommittee Hearing But Pathway Is “Uncertain”
February 27, 2025
FDA’s Next DOGE Test: How Will “Maximum” Cuts Be Defined For Agency Under OMB Memo Implementing Trump Executive Order
February 27, 2025
Prevision Policy Clips | DOGE Phase 2: OMB Guidance Calls For Agency RIF And Reorganization Plans (ARRP) By March 13
February 27, 2025
Cell Therapy Regulatory Revamp Could Mirror Device Regulations: A Risk-Based System Would Encourage Development And Discourage “Bad Actors,” CBER Says
February 26, 2025
Prevision Policy Clips | FDA Shutters Clozapine REMS
February 26, 2025
FDA Drug/Biologic Review Largely Insulated From DOGE RIFs So Far; Communications Freeze (Sort Of) Lifted
February 25, 2025
1
2
3
4
5
…
Next ›
Last »